Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin Cao

Showing results (1-10 of 1,137) with videos related to

Pageof 114
Sort By:
Cell Reports|May 1, 2025
Q&A with Bin CaoBin Cao
Chinese Medical Journal|June 22, 2013
What clinicians should know to fight against the novel avian-origin influenza A (H7N9) virus?Bin Cao
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|November 12, 2009
[Treatment of Zone II flexor tendon injury]Qi-bin Cao
Microbial Biotechnology|November 29, 2020
Engineering controllable biofilms for biotechnological applicationsManisha Mukherjee, Bin Cao
The Lancet. Infectious Diseases|August 24, 2023
The insights from SARS-CoV-2 antibody treatment for future emerging infectious diseasesYeming Wang, Bin Cao
The Lancet Regional Health. Europe|September 6, 2022
Post-infection rehabilitation of COVID-19 patients: Findings and prospectsHui Zhang, Bin Cao
Zhonghua Yi Xue Za Zhi|November 20, 2012
[Controversies in corticosteroid treatment in influenza]Nelson Lee, Bin Cao
Journal of Clinical Pharmacy and Therapeutics|November 20, 2022
Low-dose febuxostat exhibits a superior renal-protective effect and non-inferior safety profile compared to allopurinol in chronic kidney disease patients complicated with hyperuricemia: A double-centre, randomized, controlled studyNa Yang, Bin Cao
The Lancet. Infectious Diseases|June 22, 2023
Adapted vaccine strategy: facing the persistent challenges of COVID-19Lianhan Shang, Bin Cao
The European Respiratory Journal|July 30, 2021
Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19Jiuyang Xu, Bin Cao
Pageof 114

Showing results (1-10 of 1,137) with videos related to

Sort By:
Pageof 114
Cell Reports|May 1, 2025
Q&A with Bin CaoBin Cao
Chinese Medical Journal|June 22, 2013
What clinicians should know to fight against the novel avian-origin influenza A (H7N9) virus?Bin Cao
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|November 12, 2009
[Treatment of Zone II flexor tendon injury]Qi-bin Cao
Microbial Biotechnology|November 29, 2020
Engineering controllable biofilms for biotechnological applicationsManisha Mukherjee, Bin Cao
The Lancet. Infectious Diseases|August 24, 2023
The insights from SARS-CoV-2 antibody treatment for future emerging infectious diseasesYeming Wang, Bin Cao
The Lancet Regional Health. Europe|September 6, 2022
Post-infection rehabilitation of COVID-19 patients: Findings and prospectsHui Zhang, Bin Cao
Zhonghua Yi Xue Za Zhi|November 20, 2012
[Controversies in corticosteroid treatment in influenza]Nelson Lee, Bin Cao
Journal of Clinical Pharmacy and Therapeutics|November 20, 2022
Low-dose febuxostat exhibits a superior renal-protective effect and non-inferior safety profile compared to allopurinol in chronic kidney disease patients complicated with hyperuricemia: A double-centre, randomized, controlled studyNa Yang, Bin Cao
The Lancet. Infectious Diseases|June 22, 2023
Adapted vaccine strategy: facing the persistent challenges of COVID-19Lianhan Shang, Bin Cao
The European Respiratory Journal|July 30, 2021
Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19Jiuyang Xu, Bin Cao
Pageof 114